Skip to content

Study to Assess Ayurvedic Eye Treatment and Oral Medicine in Patients with Diabetic Macular Edema

Efficacy of akshyaamayanthaka anjana and shadangakwatha guggulu in the management of diabetic macular edema : a single arm interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107847
Enrollment
30
Registered
2026-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H358- Other specified retinal disorders

Interventions

None listed

Sponsors

Sri Dharmastala Manjunatheshwara College of Ayurveda and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants willing to sign the informed consent form. Participants diagnosed with DME Willingness to adhere to the study protocol, including follow-up visits. Blood sugar levels under controlled limits (HbA1c less than 10%).

Exclusion criteria

Exclusion criteria: Severe uncontrolled diabetes (HbA1c more than 10%). Individuals with active ocular infections, inflammatory conditions, or severe dry eye syndrome. Patients who have undergone intraocular surgery, laser therapy, or received intravitreal injections in the past six months. Individuals with known hypersensitivity or allergic reactions to the study formulations. Pregnant women

Design outcomes

Primary

MeasureTime frame
1.Change in Best Corrected Visual Acuity (BCVA) using Snellen s chart from baseline 2.Change in Central Macular Thickness (CMT) measured by Optical Coherence Tomography (OCT) from baseline 3.Change in metamorphopsia assessed by Amsler Grid from baseline Timepoint: 38 Days

Secondary

MeasureTime frame
Change in contrast sensitivity from baseline Change in fundus findings assessed by fundus photography from baseline Change in subjective symptoms (blurred vision, scotoma) from baseline Change in blood sugar parameters (FBS/PPBS/HbA1c) from baseline Timepoint: 38 Days

Countries

India

Contacts

Public ContactDr Ashwini M J

Sri Dharmasthala Manjunatheshwara College Of Ayurveda and Hospital, Hassan

drashwinimj@sdmcahhassan.org9448222694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026